AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
Sanofi
Sara M Tolaney; Arlene Chan; Katarina Petrakova; Suzette Delaloge; Mario Campone; Hiroji Iwata; Parvin F Peddi; Peter A Kaufman; Elisabeth De Kermadec; Qianying Liu; Patrick Cohen; Gautier Paux; Lei Wang; Nils Ternès; Eric Boitier; Seock-Ah Im